{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T06:02:22Z","timestamp":1790488942277,"version":"4.1.0"},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T00:00:00Z","timestamp":1537747200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Mental Health Technology Development Project","award":["HM15C1197"],"award-info":[{"award-number":["HM15C1197"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0204413","type":"journal-article","created":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T13:33:46Z","timestamp":1537796026000},"page":"e0204413","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":55,"title":["Use of sedative-hypnotics and the risk of Alzheimer\u2019s dementia: A retrospective cohort study"],"prefix":"10.1371","volume":"13","author":[{"given":"Joonki","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Jae","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-won","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6426-1969","authenticated-orcid":true,"given":"Aesun","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,9,24]]},"reference":[{"issue":"6","key":"ref1","doi-asserted-by":"crossref","first-page":"460","DOI":"10.5414\/CP202008","article-title":"In-depth investigation for prescribing trends of benzodiazepines in South Korea","volume":"52","author":"S-H Oh","year":"2014","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.17241\/smr.2013.4.2.51","article-title":"Pattern of Hypnotic Drug Prescription in South Korea: Health Insurance Review and Assessment Service-National Patients Sample","volume":"4","author":"S Chung","year":"2013","journal-title":"Sleep Medicine Research"},{"issue":"6","key":"ref3","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/pds.3951","article-title":"Trends in prescribing of sedative-hypnotic medications in the USA: 1993\u20132010","volume":"25","author":"CN Kaufmann","year":"2016","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1053\/smrv.1999.0076","article-title":"Chronic hypnotic use: deadly risks, doubtful benefit. REVIEW ARTICLE","volume":"4","author":"DF Kripke","year":"2000","journal-title":"Sleep medicine reviews"},{"issue":"9","key":"ref5","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s11606-007-0251-z","article-title":"The Efficacy and Safety of Drug Treatments for Chronic Insomnia in Adults: A Meta-analysis of RCTs","volume":"22","author":"N Buscemi","year":"2007","journal-title":"Journal of General Internal Medicine"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.13078\/jksrs.10005","article-title":"The Efficacy and Safety of Long-Term Use of Hypnotics","volume":"7","author":"KI Yang","year":"2010","journal-title":"J Korean Sleep Res Soc"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/0-387-27682-3_15","article-title":"Risks of chronic hypnotic use","author":"DF Kripke","year":"2006","journal-title":"Sleep and sleep disorders"},{"key":"ref8","first-page":"89","article-title":"Progress in Brain Research","volume":"190","author":"A Vermeeren","year":"2011"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2174\/1381612023396654","article-title":"Cognitive and Sedative Effects of Benzodiazepine Use","volume":"8","author":"SE Buffett-Jerrott","year":"2002","journal-title":"Current Pharmaceutical Design"},{"issue":"8","key":"ref10","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.arcmed.2012.11.003","article-title":"Epidemiology of Dementias and Alzheimer\u2019s Disease","volume":"43","author":"AL Sosa-Ortiz","year":"2012","journal-title":"Archives of Medical Research"},{"key":"ref11","unstructured":"Prince M, Comas-Herrera A, Knapp M, Guerchet M, Karagiannidou M. World Alzheimer report 2016: improving healthcare for people living with dementia: coverage, quality and costs now and in the future. 2016."},{"issue":"7","key":"ref12","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3346\/jkms.2014.29.7.903","article-title":"Prevalence and Trends of Dementia in Korea: A Systematic Review and Meta-Analysis","volume":"29","author":"YJ Kim","year":"2014","journal-title":"J Korean Med Sci"},{"key":"ref13","unstructured":"Metrics IfH, Evaluation. GBD compare. IHME, University of Washington Seattle^ eWA WA; 2015."},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/1471-2458-13-293","article-title":"Burden of disease due to dementia in the elderly population of Korea: present and future","volume":"13","author":"J-H Park","year":"2013","journal-title":"BMC Public Health"},{"issue":"10","key":"ref15","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s40264-015-0319-3","article-title":"Benzodiazepine Use and Risk of Developing Alzheimer\u2019s Disease or Vascular Dementia: A Case\u2013Control Analysis","volume":"38","author":"P Imfeld","year":"2015","journal-title":"Drug Safety"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"i90","DOI":"10.1136\/bmj.i90","article-title":"Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study","volume":"352","author":"SL Gray","year":"2016","journal-title":"BMJ"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00002093-199803000-00002","article-title":"Benzodiazepines May Have Protective Effects Against Alzheimer Disease","volume":"12","author":"J Fastbom","year":"1998","journal-title":"Alz Dis Assoc Dis"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0895-4356(01)00453-X","article-title":"Benzodiazepine use and risk of dementia: a nested case\u2013control study","volume":"55","author":"R Lagnaoui","year":"2002","journal-title":"J Clin Epidemiol"},{"issue":"10","key":"ref19","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1136\/jech-2011-200314","article-title":"Benzodiazepine use and risk of dementia: evidence from the Caerphilly Prospective Study (CaPS)","volume":"66","author":"J Gallacher","year":"2012","journal-title":"J Epidemiol Community Health"},{"issue":"7","key":"ref20","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/JGP.0b013e3181a65210","article-title":"The association between dementia and long-term use of benzodiazepine in the elderly: nested case-control study using claims data","volume":"17","author":"CS Wu","year":"2009","journal-title":"The American journal of geriatric psychiatry: official journal of the American Association for Geriatric Psychiatry"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e6231","DOI":"10.1136\/bmj.e6231","article-title":"Benzodiazepine use and risk of dementia: prospective population based study","volume":"345","author":"SB de Gage","year":"2012","journal-title":"Bmj"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"g5205","DOI":"10.1136\/bmj.g5205","article-title":"Benzodiazepine use and risk of Alzheimer\u2019s disease: case-control study","volume":"349","author":"S Billioti de Gage","year":"2014","journal-title":"BMJ: British Medical Journal"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/JGP.0b013e3181e049ca","article-title":"Effect of benzodiazepine discontinuation on dementia risk","volume":"19","author":"C-S Wu","year":"2011","journal-title":"The American Journal of Geriatric Psychiatry"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3233\/JAD-151006","article-title":"Regular Benzodiazepine and Z-Substance Use and Risk of Dementia: An Analysis of German Claims Data","volume":"54","author":"W Gomm","year":"2016","journal-title":"Journal of Alzheimer's Disease"},{"issue":"11","key":"ref25","doi-asserted-by":"crossref","first-page":"e49113","DOI":"10.1371\/journal.pone.0049113","article-title":"Risk of Dementia in Patients with Insomnia and Long-term Use of Hypnotics: A Population-based Retrospective Cohort Study","volume":"7","author":"P-L Chen","year":"2012","journal-title":"PloS one"},{"issue":"5","key":"ref26","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jalz.2015.10.006","article-title":"Benzodiazepine, psychotropic medication, and dementia: A population-based cohort study","volume":"12","author":"D Shash","year":"2016","journal-title":"Alzheimers Dement"},{"issue":"5","key":"ref27","doi-asserted-by":"crossref","first-page":"e0127836","DOI":"10.1371\/journal.pone.0127836","article-title":"Association between Benzodiazepine Use and Dementia: A Meta-Analysis","volume":"10","author":"G Zhong","year":"2015","journal-title":"PloS one"},{"key":"ref28","article-title":"Guidelines for ATC classification and DDD assignment 2013","year":"2012"},{"issue":"5","key":"ref29","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/ana.21509","article-title":"Prodromal Alzheimer&apos;s disease: successive emergence of the clinical symptoms","volume":"64","author":"H Amieva","year":"2008","journal-title":"Ann Neurol"},{"issue":"04","key":"ref30","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1017\/S2045796013000358","article-title":"Benzodiazepines and risk of dementia: true association or reverse causation?","volume":"22","author":"C Barbui","year":"2013","journal-title":"Epidemiology and psychiatric sciences"},{"issue":"9","key":"ref31","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer&apos;s disease","volume":"367","author":"RJ Bateman","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"ref32","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S1474-4422(08)70169-8","article-title":"Alzheimer&apos;s disease and vascular dementia in developing countries: prevalence, management, and risk factors","volume":"7","author":"RN Kalaria","year":"2008","journal-title":"The Lancet Neurology"},{"issue":"4","key":"ref33","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11883-004-0056-z","article-title":"Cardiovascular risk factors and Alzheimer\u2019s disease","volume":"6","author":"JA Luchsinger","year":"2004","journal-title":"Current Atherosclerosis Reports"},{"issue":"6","key":"ref34","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.biopsych.2009.02.013","article-title":"Meta-Analysis of Alzheimer&apos;s Disease Risk with Obesity, Diabetes, and Related Disorders","volume":"67","author":"LA Profenno","year":"2010","journal-title":"Biological Psychiatry"},{"issue":"5","key":"ref35","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s002280100326","article-title":"Benzodiazepine use in an elderly community-dwelling population","volume":"57","author":"A Fourrier","year":"2001","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"ref36","first-page":"e15","article-title":"Cohort Profile: The National Health Insurance Service\u2013National Sample Cohort (NHIS-NSC), South Korea","volume":"46","author":"J Lee","year":"2017","journal-title":"International Journal of Epidemiology"},{"issue":"4","key":"ref37","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1214\/aos\/1176345976","article-title":"Cox&apos;s Regression Model for Counting Processes: A Large Sample Study","volume":"10","author":"PK Andersen","year":"1982","journal-title":"The Annals of Statistics"},{"issue":"3","key":"ref38","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/pds.1357","article-title":"Immortal time bias in observational studies of drug effects","volume":"16","author":"S. Suissa","year":"2007","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"11","key":"ref39","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.jclinepi.2012.04.008","article-title":"Time-dependent study entries and exposures in cohort studies can easily be sources of different and avoidable types of bias","volume":"65","author":"M Wolkewitz","year":"2012","journal-title":"J Clin Epidemiol"},{"issue":"24","key":"ref40","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1002\/sim.2098","article-title":"Choice of time-scale in Cox&apos;s model analysis of epidemiologic cohort data: a simulation study","volume":"23","author":"ACM Thi\u00e9baut","year":"2004","journal-title":"Statistics in Medicine"},{"issue":"3","key":"ref41","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/da.22584","article-title":"The association of antidepressant drug usage with cognitive impairment or dementia, including Alzheimer disease: A systematic review and meta\u2010analysis","volume":"34","author":"J Moraros","year":"2017","journal-title":"Depression and Anxiety"},{"issue":"1","key":"ref42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40263-015-0305-4","article-title":"The Benzodiazepine\u2013Dementia Disorders Link: Current State of Knowledge","volume":"30","author":"A Pariente","year":"2016","journal-title":"CNS Drugs"},{"issue":"1\u20132","key":"ref43","first-page":"105","article-title":"Incidence of and Risk Factors for Alzheimer&apos;s Disease and Mild Cognitive Impairment in Korean Elderly","volume":"39","author":"JB Bae","year":"2015","journal-title":"Dementia and Geriatric Cognitive Disorders"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0206094","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T00:00:00Z","timestamp":1539648000000}}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0204413","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T02:41:57Z","timestamp":1540348917000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0204413"}},"subtitle":[],"editor":[{"given":"Andrea","family":"Romigi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,9,24]]},"references-count":43,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,9,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0204413","relation":{"correction":[{"id-type":"doi","id":"10.1371\/journal.pone.0206094","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,24]]}}}